Opioid MOA & Receptors - The Brain's Bliss Buttons

- Receptors: Opioids are agonists at three main G-protein coupled receptors (GPCRs): Mu (μ), Delta (δ), and Kappa (κ).
- Cellular MOA: They act on both presynaptic and postsynaptic neurons.
- ↓ Presynaptic Ca²⁺ influx → ↓ release of neurotransmitters (e.g., Substance P, glutamate).
- ↑ Postsynaptic K⁺ efflux → hyperpolarization → ↓ neuronal signaling.
- Key Receptor Functions:
- μ (Mu): Analgesia, euphoria, respiratory depression, miosis, constipation. 📌 Mu = Most effects.
- κ (Kappa): Spinal analgesia, sedation, miosis.
⭐ Opioids primarily exert their powerful analgesic effects by acting on μ-receptors in the spinal cord (substantia gelatinosa) and supraspinal sites (e.g., periaqueductal gray).
Opioid Classification - The Agonist & Antagonist Cast
| Class | Mechanism & Key Drugs | Clinical Notes |
|---|---|---|
| Full Agonists | Strong μ-receptor agonists providing maximal analgesia. | Morphine, fentanyl, methadone, meperidine. Used for severe pain; high abuse potential. |
| Partial Agonists | Mixed agonist-antagonist activity; act as agonists at some receptors and antagonists at others. | Buprenorphine (μ-partial agonist, κ-antagonist), nalbuphine, butorphanol. Can precipitate withdrawal in opioid-dependent patients. |
| Antagonists | Competitive antagonists at all opioid receptors; displace agonists to reverse effects. | Naloxone (short-acting for acute overdose), naltrexone (long-acting for relapse prevention). |
Uses & Side Effects - Pain Relief and Its Perils

-
Primary Uses
- Analgesia: Moderate to severe pain.
- Cough suppression (dextromethorphan, codeine).
- Diarrhea treatment (loperamide, diphenoxylate).
- Anesthesia adjunct (fentanyl).
-
Adverse Effects
- CNS: Sedation, euphoria, miosis (pinpoint pupils).
- Respiratory: ↓ Respiratory rate & depth.
- GI: Nausea, vomiting, constipation (no tolerance).
- CV: Hypotension, bradycardia.
- GU: Urinary retention.
- Skin: Pruritus (histamine release).
- Tolerance and physical dependence with long-term use.
⭐ Opioid Overdose Triad: Coma, respiratory depression, and pinpoint pupils (miosis). Treat with naloxone.
Overdose & Withdrawal - When The Bliss Ends
- Overdose Triad: Coma, respiratory depression, miosis (pinpoint pupils).
- Management: Naloxone (opioid antagonist). Caution: short half-life may require repeat doses.
⭐ Naloxone can precipitate severe, acute withdrawal in opioid-dependent individuals.
- Withdrawal Symptoms: Anxiety, lacrimation, rhinorrhea, yawning, sweating, piloerection ("cold turkey"), mydriasis.
- Treatment: Supportive. Clonidine (↓ autonomic hyperactivity). For long-term detox: methadone (long-acting agonist) or buprenorphine (partial agonist).
High‑Yield Points - ⚡ Biggest Takeaways
- Opioids bind to μ, δ, and κ receptors, causing analgesia, euphoria, and sedation.
- The classic triad of opioid toxicity is coma, pinpoint pupils (miosis), and respiratory depression.
- Naloxone is a competitive antagonist used to reverse opioid overdose.
- Tolerance develops to most effects, but not to miosis or constipation.
- Withdrawal is managed with long-acting agents like methadone or buprenorphine.
- Co-administration with other CNS depressants (e.g., benzodiazepines) risks fatal respiratory depression.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app